ICCC

NASDAQ · Equity

ImmuCell Corporation

US Healthcare Biotechnology

Latest week
29 May 2026
Close
10.240000
Fair value
5.416300
Expectation
Undecided 46.18%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
10.24
12-Week Change
60.75%
Trend Signal
Active
Expectation
Undecided 46.18%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
26.78
Market Dynamics
1.62

Over the latest 12 completed weeks ending 2026-05-29, ICCC rose 60.75%, moving from 6.37 to 10.24. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 26.78 and has improved across the 12-week window. Market Dynamics is 1.62 on the latest week. Expectation is undecided at 46.18%.